Catharina Böhme Medizinerin, Biochemikerin
Böhme, Catharina Cora 1976-
VIAF ID: 60025912 (Personal)
Permalink: http://viaf.org/viaf/60025912
Preferred Forms
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India. | |
Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platform | |
Aiming for zero tuberculosis transmission in low-burden countries. | |
An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics". | |
Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infections | |
"Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities. | |
Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India. | |
Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study | |
Comparative performance of four rapid Ebola antigen-detection lateral flow immunoassays during the 2014-2016 Ebola epidemic in West Africa | |
Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. | |
Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India | |
Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection | |
Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies | |
Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB | |
Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments | |
Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis | |
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India | |
Importance of diagnostics in epidemic and pandemic preparedness | |
Katalytische Intermediate bei Disulfidreduktasen von Mensch und Malariaerreger Beiträge zur Entwicklung synkatalytischer Inhibitoren als Chemotherapeutika | |
Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases. | |
Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population | |
The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis | |
Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study | |
Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology | |
Tuberculosis Diagnostics in the New Millennium: Role in TB Identification and Control | |
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India | |
Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? |